UPDATE: AbbVie (ABBV) Declines 5%, Coherus BioSciences (CHRS) Halted as Humira Patent to Be Reviewed
Tweet Send to a Friend
(Updated - May 17, 2016 10:07 AM EDT)AbbVie (NYSE: ABBV) declined over 5 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
